Financial Perspectives’s BeOne Medicines Ltd ONC Stock Holding History

Financial Perspectives’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$168K	Hold	588	–	–	0.04%	190
2026 Q1	$175K	Hold	588	–	–	0.05%	176
2025 Q4	$179K	Hold	588	–	–	0.05%	167
2025 Q3	$200K	Hold	588	–	–	0.06%	161
2025 Q2	$142K	Hold	588	–	–	0.04%	184
2025 Q1	$160K	Hold	588	–	–	0.05%	161
2024 Q4	$109K	Sell	588 -281	-32%	-$57.4K	0.04%	205
2024 Q3	$195K	Hold	869	–	–	0.07%	142
2024 Q2	$124K	Hold	869	–	–	0.05%	179
2024 Q1	$136K	Hold	869	–	–	0.05%	172
2023 Q4	$157K	Hold	869	–	–	0.06%	154
2023 Q3	$156K	Hold	869	–	–	0.07%	147
2023 Q2	$155K	Hold	869	–	–	0.07%	148
2023 Q1	$187K	Hold	869	–	–	0.09%	126
2022 Q4	$191K	Hold	869	–	–	0.1%	124
2022 Q3	$117K	Hold	869	–	–	0.07%	158
2022 Q2	$141K	Hold	869	–	–	0.08%	144
2022 Q1	$164K	Buy	869 +129	+17%	+$27.4K	0.08%	145
2021 Q4	$200K	Buy	740 +198	+37%	+$66.9K	0.09%	126
2021 Q3	$197K	Sell	542 -629	-54%	-$206K	0.1%	120
2021 Q2	$402K	Hold	1,171	–	–	0.2%	77
2021 Q1	$408K	Hold	1,171	–	–	0.22%	72
2020 Q4	$303K	Buy	1,171 +264	+29%	+$72.7K	0.17%	86
2020 Q3	$260K	Hold	907	–	–	0.17%	81
2020 Q2	$171K	Hold	907	–	–	0.12%	100
2020 Q1	$112K	Buy	907 +387	+74%	+$60.5K	0.09%	109
2019 Q4	$86.2K	Buy	+520	New	+$86.4K	0.06%	133

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Financial Perspectives's ONC Position: Q2 2026 in Review

Financial Perspectives held its BeOne Medicines Ltd (ONC) position steady in Q2 2026 at 588 shares worth $168K. The position accounts for 0.04% of the portfolio, ranked #190.

Financial Perspectives first reported a position in ONC in Q4 2019 and has held it in 27 quarters since. The position peaked at $408K in Q1 2021. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

Financial Perspectives held 588 shares of BeOne Medicines Ltd worth $168K as of Q2 2026.
Financial Perspectives left its BeOne Medicines Ltd share count unchanged in Q2 2026.
BeOne Medicines Ltd made up 0.04% of Financial Perspectives's portfolio in Q2 2026, its #190 holding.
Financial Perspectives first reported a position in BeOne Medicines Ltd in Q4 2019 and has held it in 27 quarters since.
Financial Perspectives's BeOne Medicines Ltd position peaked at $408K in Q1 2021.
282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Financial Perspectives's 13F filing for Q2 2026, filed 24 Jul 2026.